35. According to the Institute for Safe Medication Practices (ISMP), which of the following medication classes is considered high-alert in acute care settings?
Answer: A
Anticoagulants are considered high-alert medications in acute care settings.
In acute care settings, anticoagulants are classified as high-alert medications due to their potential to cause significant harm if used incorrectly. Their therapeutic window is narrow, and errors in dosing can lead to serious complications such as bleeding.
A) Anticoagulants
This option is correct because anticoagulants, including medications like warfarin and heparin, are recognized by the ISMP as high-alert due to the serious risks associated with their use. Improper management of these medications can lead to life-threatening conditions, making them a focal point for safety measures in healthcare settings.
B) Antihistamines
Antihistamines are not classified as high-alert medications. While they can have side effects and interactions, they typically do not pose the same level of risk for severe harm as anticoagulants. Therefore, they do not require the heightened focus on safety that high-alert medications do.
C) Bronchodilators
Bronchodilators are also not considered high-alert medications. They are generally used to manage respiratory conditions and, while they must be used correctly to avoid side effects, they do not carry the same level of risk that would classify them as high-alert by ISMP standards.
D) Antispasmodics
Antispasmodics do not fall under the category of high-alert medications. These drugs are used to relieve muscle spasms and discomfort, but they do not present the same high risk of serious harm in acute care settings as anticoagulants do.
Conclusion
Anticoagulants are distinctly categorized as high-alert medications due to the severe consequences of dosing errors, which can include significant bleeding and complications. In contrast, antihistamines, bronchodilators, and antispasmodics do not present the same level of risk and therefore are not considered high-alert. This classification emphasizes the need for vigilant monitoring and management of anticoagulant therapy in acute care environments.